Skip to main content
Erschienen in: Tumor Biology 2/2014

01.02.2014 | Research Article

Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies

verfasst von: Qingtong Ma, Yumei Zhao, Shoufeng Wang, Xiaoyan Zhang, Jinling Zhang, Mei Du, Liang Li, Yun Zhang

Erschienen in: Tumor Biology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The relationship of bladder cancer with the presence of X-ray cross-complementing group 3(XRCC3) genetic polymorphismThr241Met has been reported with inconsistent results. The objective of this study was to quantitatively evaluate the association between this polymorphism and bladder cancer susceptibility. A comprehensive research was conducted through PubMed, Medline, Embase, and Web of Science databases up to Aug. 20, 2013. Pooled odds ratio and 95 % confidence interval were calculated using a fixed or random effects model. Statistical analysis was performed with Stata 12.0 software. Of the 18 case–control studies selected for this meta-analysis, a total of 5,667 bladder cancer cases and 7,609 controls were included. The combined results based on all studies suggested that XRCC3 Thr241Met was associated with bladder cancer risk under homozygote and recessive models. When stratifying for ethnicity, significant association was found in Caucasians under homozygote and recessive models. This meta-analysis suggests that XRCC3 Thr241Met polymorphism is a risk factor for bladder cancer risk. However, further well-designed studies are required to confirm our findings.
Literatur
1.
Zurück zum Zitat Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis. 2004;25:729–34.PubMedCrossRef Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis. 2004;25:729–34.PubMedCrossRef
2.
Zurück zum Zitat Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl. 2000;205:105–15.PubMedCrossRef Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl. 2000;205:105–15.PubMedCrossRef
3.
Zurück zum Zitat Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–7.PubMedCrossRef Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–7.PubMedCrossRef
4.
Zurück zum Zitat Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair, and the cancer connection. Nat Genet. 2001;27:247–54.PubMedCrossRef Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair, and the cancer connection. Nat Genet. 2001;27:247–54.PubMedCrossRef
5.
Zurück zum Zitat Bishop DK, Ear U, Bhattacharyya A, et al. XRCC3 is required for assembly of Rad51 complexes in vivo. J Biol Chem. 1998;273:21482–8.PubMedCrossRef Bishop DK, Ear U, Bhattacharyya A, et al. XRCC3 is required for assembly of Rad51 complexes in vivo. J Biol Chem. 1998;273:21482–8.PubMedCrossRef
6.
Zurück zum Zitat Aka P, Mateuca R, Buchet JP, Thierens H, Kirsch-Volders M. Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionizing radiations? Mutat Res. 2004;556:169–81.PubMedCrossRef Aka P, Mateuca R, Buchet JP, Thierens H, Kirsch-Volders M. Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionizing radiations? Mutat Res. 2004;556:169–81.PubMedCrossRef
7.
Zurück zum Zitat Angelini S, Kumar R, Carbone F, Maffei F, Forti GC, Violante FS, et al. Micronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genes. Mutat Res. 2005;570:105–17.PubMedCrossRef Angelini S, Kumar R, Carbone F, Maffei F, Forti GC, Violante FS, et al. Micronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genes. Mutat Res. 2005;570:105–17.PubMedCrossRef
8.
Zurück zum Zitat Davey SG, Egger M. Meta-analyses of randomized controlled trials. Lancet. 1997;350:1182. Davey SG, Egger M. Meta-analyses of randomized controlled trials. Lancet. 1997;350:1182.
9.
Zurück zum Zitat Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef
10.
Zurück zum Zitat Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
11.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRef
12.
Zurück zum Zitat Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.PubMedCrossRef Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.PubMedCrossRef
13.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef
14.
Zurück zum Zitat Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case–control study. Int J Cancer. 2001;92:562–7.PubMedCrossRef Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case–control study. Int J Cancer. 2001;92:562–7.PubMedCrossRef
15.
Zurück zum Zitat Stern MC, Umbach DM, Lunn RM, et al. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:939–43.PubMed Stern MC, Umbach DM, Lunn RM, et al. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:939–43.PubMed
16.
Zurück zum Zitat Shen M, Hung RJ, Brennan P, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case–control study in northern Italy. Cancer Epidemiol Biomarkers Prev. 2003;12:1234–40.PubMed Shen M, Hung RJ, Brennan P, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case–control study in northern Italy. Cancer Epidemiol Biomarkers Prev. 2003;12:1234–40.PubMed
17.
Zurück zum Zitat Matullo G, Guarrera S, Sacerdote C, et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case–control study. Cancer Epidemiol Biomarkers Prev. 2005;14:2569–78.PubMedCrossRef Matullo G, Guarrera S, Sacerdote C, et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case–control study. Cancer Epidemiol Biomarkers Prev. 2005;14:2569–78.PubMedCrossRef
18.
Zurück zum Zitat Broberg K, Björk J, Paulsson K, et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26:1263–71.PubMedCrossRef Broberg K, Björk J, Paulsson K, et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26:1263–71.PubMedCrossRef
19.
Zurück zum Zitat Matullo G, Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. 2006;27:997–1007.PubMedCrossRef Matullo G, Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. 2006;27:997–1007.PubMedCrossRef
20.
Zurück zum Zitat Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006;78:464–79.PubMedCentralPubMedCrossRef Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006;78:464–79.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Figueroa JD, Malats N, Rothman N, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis. 2007;28:1788–93.PubMedCrossRef Figueroa JD, Malats N, Rothman N, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis. 2007;28:1788–93.PubMedCrossRef
22.
Zurück zum Zitat Hao G, Zhang Y, Zhang W, et al. Relationship between XRCC3 gene polymorphism and bladder cancer in the Han population. J Shandong U. 2008;46:612–5. Hao G, Zhang Y, Zhang W, et al. Relationship between XRCC3 gene polymorphism and bladder cancer in the Han population. J Shandong U. 2008;46:612–5.
23.
Zurück zum Zitat Andrew AS, Karagas MR, Nelson HH, et al. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered. 2008;65:105–18.PubMedCrossRef Andrew AS, Karagas MR, Nelson HH, et al. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered. 2008;65:105–18.PubMedCrossRef
24.
Zurück zum Zitat Fontana L, Bosviel R, Delort L, et al. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res. 2008;28:1853–6.PubMed Fontana L, Bosviel R, Delort L, et al. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res. 2008;28:1853–6.PubMed
25.
Zurück zum Zitat Andrew AS, Mason RA, Kelsey KT, et al. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol Lett. 2009;187:10–4.PubMedCentralPubMedCrossRef Andrew AS, Mason RA, Kelsey KT, et al. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol Lett. 2009;187:10–4.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Yang Q, Chen K, Han Q. Studies on polymorphisms of XRCC1, XRCC3 and bladder cancer risk. Chin J Misdiagn. 2009;9:8393–4. Yang Q, Chen K, Han Q. Studies on polymorphisms of XRCC1, XRCC3 and bladder cancer risk. Chin J Misdiagn. 2009;9:8393–4.
27.
Zurück zum Zitat Narter KF, Ergen A, Agaçhan B, et al. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res. 2009;29:1389–93.PubMed Narter KF, Ergen A, Agaçhan B, et al. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res. 2009;29:1389–93.PubMed
28.
Zurück zum Zitat Gangwar R, Ahirwar D, Mandhani A, et al. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutat Res. 2009;680:56–63.PubMedCrossRef Gangwar R, Ahirwar D, Mandhani A, et al. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutat Res. 2009;680:56–63.PubMedCrossRef
29.
Zurück zum Zitat Mittal RD, Gangwar R, Mandal RK, Srivastava P, Ahirwar DK. Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Mol Biol Rep. 2012;39(2):1667–75.PubMedCrossRef Mittal RD, Gangwar R, Mandal RK, Srivastava P, Ahirwar DK. Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Mol Biol Rep. 2012;39(2):1667–75.PubMedCrossRef
30.
Zurück zum Zitat Zhu X, Zhong Z, Zhang X, Zhao X, Xu R, Ren W, et al. DNA repair gene XRCC3 T241m polymorphism and bladder cancer risk in a Chinese population. Genet Test Mol Biomarkers. 2012;16(6):640–3.PubMedCrossRef Zhu X, Zhong Z, Zhang X, Zhao X, Xu R, Ren W, et al. DNA repair gene XRCC3 T241m polymorphism and bladder cancer risk in a Chinese population. Genet Test Mol Biomarkers. 2012;16(6):640–3.PubMedCrossRef
31.
Zurück zum Zitat Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20:439–44.PubMedCrossRef Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20:439–44.PubMedCrossRef
32.
Zurück zum Zitat Ioannidis JP, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120–32.PubMedCrossRef Ioannidis JP, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120–32.PubMedCrossRef
Metadaten
Titel
Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies
verfasst von
Qingtong Ma
Yumei Zhao
Shoufeng Wang
Xiaoyan Zhang
Jinling Zhang
Mei Du
Liang Li
Yun Zhang
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 2/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1203-3

Weitere Artikel der Ausgabe 2/2014

Tumor Biology 2/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.